在神经退行症中TDP-43的结构,功能,病理机制和向
Xudong Zhang1, Baiwen Zhang1, Yaxin Shang2
1The First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China; The First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
TDP-43蛋白质的改变与神经退行性疾病有关. 修改导致TDP-43病理聚集,影响神经元功能和疾病发病.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 该TARDNA结合蛋白 (TDP-43) 与神经退行性疾病的病因有关.
- 了解TDP-43的作用对于开发有效治疗这些疾病至关重要.
研究的目的:
- 分析TDP-43蛋白修饰在神经退行性疾病中的生物和病理影响.
- 探索TDP-43在神经元生长,轴突引导和突触活动中的参与.
- 概述潜在的治疗策略和未来的研究方向.
主要方法:
- 对TDP-43蛋白质结构,修饰和RNA功能的分析.
- 研究TDP-43的生物效应,包括氧化应激,炎症和自.
- 检查TDP-43与神经元发育和功能之间的关联.
主要成果:
- 通过酸化,无化,SUMOylation和乙化,TDP-43经历了结构和功能上的变化.
- 这些修改促进了TDP-43核出口和病态聚合.
- TDP-43参与氧化应激,炎症反应,自和血管生成.
- TDP-43直接影响神经元生长,轴突引导和突触活动.
结论:
- 改变的TDP-43蛋白质有助于神经退行性疾病的发病.
- 针对TDP-43的修改和聚合可能提供治疗潜力.
- 对TDP-43的机制进行进一步的研究可以指导开发新型治疗方法.
更多相关视频
11:03Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets
Published on: February 10, 2020
06:58Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
相关概念视频
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Lysosomal Hydrolases
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
